COVID-19, plasma, and hypogammaglobulinemia
In this issue of Blood, Hueso et al1 report a study of COVID-19 convalescent plasma (CCP) in patients with COVID-19 and negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology with severe immunodeficiency due to prior treatment with anti-CD20 monoclonal antibodies. The study...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
http://www.hematology.org/
2020
|
| Summary: | In this issue of Blood, Hueso et al1 report a study of COVID-19 convalescent plasma (CCP) in patients with COVID-19 and negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology with severe immunodeficiency due to prior treatment with anti-CD20 monoclonal antibodies. The study reports on the safety and efficacy of COVID-19 CCP in 17 patients with profound B-cell lymphopenia and protracted COVID-19 disease.
|
|---|